ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2011 - 2026)

ClearPoint Neuro has disclosed Depreciation & Amortization (CF) across 15 years of filings, most recently posting $86000.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $86000.0, down 62.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 20.26% YoY), and the FY2025 annual result was $1.3 million, up 35.97% from the prior year.
• Depreciation & Amortization (CF) came in at $86000.0 for Q1 2026 at ClearPoint Neuro, down from $690000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $690000.0 in Q4 2025 to a low of $36000.0 in Q4 2023.
• The 5-year median for Depreciation & Amortization (CF) is $213000.0 (2022), against an average of $201352.9.
• Across the five-year window, Depreciation & Amortization (CF) slumped 72.93% in 2023 and soared 541.67% in 2024, its largest moves.
• ClearPoint Neuro's Depreciation & Amortization (CF) stood at $133000.0 in 2022, then plunged by 72.93% to $36000.0 in 2023, then jumped by 541.67% to $231000.0 in 2024, then soared by 198.7% to $690000.0 in 2025, then sank by 87.54% to $86000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $86000.0 (Q1 2026), $690000.0 (Q4 2025), and $66000.0 (Q3 2025), per Business Quant data.